Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines

British Journal of Cancer

Volumn 76, Issue 2, 1997, Pages 189-197

  Braakhuis, B J M ^a   Klaassen, I ^a   Van Der Leede, B M ^b   Cloos, J ^a   Brakenhoff, R H ^a   Copper, M P ^a   Teerlink, T ^a   Hendriks, H F J ^c   Van Der Saag, P T ^b   Snow, G B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HUBRECHT INSTITUTE   (Netherlands)

^c TNO   (Netherlands)

Author keywords

CRABP II; Head and neck cancer; Metabolism; Retinoid; Squamous

Indexed keywords

ALITRETINOIN; ISOTRETINOIN; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOID;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL METABOLISM; CONTROLLED STUDY; CULTURE MEDIUM; DRUG BLOOD LEVEL; DRUG METABOLISM; HEAD CANCER; HOMEOSTASIS; HUMAN; HUMAN CELL; NECK CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 8544270924     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.361     Document Type: Article

References (47)

1. Adamson PC, Boylan JF, Balis FM, Murphy RF Godwin KA, Gudas LJ and Poplack DG (1993a) Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res 53: 472-476
2. Adamson PC, Pitot HC, Balis FM, Rubin J, Murphy RF and Poplack DG (1993b) Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst 85: 993-996
3. Aström A, Tavakkol A, Pettersson U, Cromie M, Elder JT and Voorhees JJ (1991) Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro. J Biol Chem 266: 17662-17666
4. Bavik CO, Levy F, Hellman U, Wernstedt C and Eriksson U (1993) The retinal pigment epithelial membrane receptor for plasma retinol-binding protein-isolation and cDNA cloning of the 63-kda protein. J Biol Chem 268: 20540-20546
5. Benner SE, Lippman SM and Hong WK (1993) Retinoids in head and neck cancer, In Retinoids in Oncology, Hong WK and Lotan R (eds), pp. 203 223. Marcel Dekker: New York
6. Blaner WS and Olson JA (1944) Retinol and retinoic acid metabolism. In The Retinoids Biology, Chemistry and Medicine. 2nd edn, Sporn MB. Roberts AR and Goodman DS (eds). pp. 229-256. Raven Press: New York
7. Blumberg B, Bolado J, Derguine F, Craig AJ, Moreno TA, Chakravarti D, Heyman, Buck J. Evans RM (1996) Novel retinoic acid receptor ligands in Xenopus embryos. Proc Nutl Acad Sci USA 93: 4873-4878
8. Braakhuis BJM, Jansen G, Noordhuis P, Kegel A and Peters GJ (1993) Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaminopterin against human head and neck squamous cell carcinoma Biochem Pharmacol 40: 2155-2161
9. Boylan JF and Gudas LJ (1992) The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 267: 21486-21491
10. Carey TE (1985) Establishment of epidermoid carcinoma cell lines. In Head and Neck Cancer, Wittes RE (ed.), pp. 287-314. John Wiley: New York
11. Copper MP, Klaassen I, Brekenhoff RH, Cloos J, Snow GB and Braakhuis BJM (1997) All-trans Retinoic acid induced gene-expression and growth inhibition in head and neck cancer cell lines. Oral Oncol (in press)
12. Dawson MI and Hobbs PD (1994) The synthetic chemistry of retinoids. In The Retinoids Biology, Chemistry and Medicine, 2nd edn, Sporn MB, Roberts AR and Goodman DS (eds.), pp. 5 178. Raven Press: New York
13. Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A, Ely KR, Shroot B and Fontana JA (1995) Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res 55: 4446-4451
14. Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L and Chomienne C (1993) Resistance to all-trans-retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia - study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Biol 82: 2175-2181
15. Eckhoff C and Nau H (1990) Identification and quantitation of all-trans- and 13-cis-retinoic acid in human plasma. J Lip Res 31: 1445-1454
16. Eckhoff C, Collins MD and Nau H (1991) Human plasma all-trans-, 13-cis- and 13-cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: Comparison to retinol and retinyl ester plasma levels. J Nutr 121: 1016-1025
17. Feinberg AP and Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13
18. Gough NM (1988) Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 173: 93-95
19. Griffiths CEM, Elder JT, Bernard BA, Rossio P, Cromie MA, Finkel LJ, Shroot B and Voorhees JJ (1993) Comparison of CD271 (adapalene) and all-trans-retinoic acid in human skin dissociation of epidermal effects and CRABP-II messenger RNA expression. J Invest Dermatol 101: 325-328
20. Harding P and Duester G (1992) Retinoic acid activation and thyroid hormone repression of the human alcohol dehydrogenase gene ADH3. J Biol Chem 267: 14145-14150
21. Hong WK, Endicott J and Itri L (1986) 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-1505
22. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW and Goepfert H (1990) Prevention of second primary tumors with isotretinion in squamous cell carcinoma of the head and neck. N Engl Med 323: 795-801
23. Hong WK and Itri LM (1994) Retinoids and human cancer. In The Retinoids. Biology, Chemistry and Medicine, 2nd edn, Sporn MB. Roberts AR and Goodman DS (eds.), pp. 597-631. Raven Press: New York
24. Jetten AM, Kim JS, Sacks PG, Rearick JI, Lotan D, Hong HK and Lotan R (1990) Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid. Int J Cancer 45: 145-202
25. Koch HF (1978) Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. J Maxillofac Surg 6: 59-63
26. Kurlandsky SB, Gamble MV, Ramakrishnan R and Blaner WS (1995) Plasma delivery of retinoic acid to tissues in the rat. J Biol Chem 270: 17850 17857
27. Lee JS, Newman RA, Lippman SM, Huber MH, Minor T, Raber MN, Krakoff IH and Hong WK (1993) Phase-I evaluation of all-trans-retinoic acid in adults with solid tumors. J Clin Oncol 11: 959-966
28. Lippman SM, Kessler JF, Al-Sarraf M, Alberts DS, Itri LM and Mattox D (1988) Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest New Drugs 6: 51-56
29. Lotan R (1993) Retinoids and squamous cell differentiation. In Retinoids in Oncology, Hong WK and Lotan R (eds), pp. 43-73. Marcel Dekker: New York
30. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ and Hong WK (1995) Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin, N Engl J Med 332: 1405-1410
31. Mangelsdorf DJ, Umesono K and Evans RM (1994) The retinoid receptors. In The Retinoids, Biology, Chemistry, and Medicine, 2nd edn, Spron MB. Roberts AR and Goodman DS (eds), pp. 319-351. Raven Press: New York
32. Martini R and Murray M (1993) Participation of p450-3a enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation. Arch Biochem Biophys 303: 57-66
33. Muindi JF, Frankel SE, Miller WH, Young WC, Dmitrovsky E and Warell RP (1992) Continuous treatment with all-trans-retinoic acid causes a progressive decrease in plasma concentrations: implications of relapse and resistance in acute promyelocytic leukemia. Blood 79: 299-303
34. Muindi JF, Scher HI, Rigas JR, Wurrell RP and Young CW (1994) Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer. Cancer Res 54: 2125-2128
35. Napoli JL, Boerman MHEM, Chai X, Zhai Y and Fiorella PD (1995) Enzymes and binding proteins affecting retinoic acid concentrations. J Steroid Biochem Mol Biol 53: 497-502
36. Pijnappel WWM, Hendriks HFJ, Folkers GE, Van Den Brink CE, Dekker EJ, Edelenhosch C, Van Der Saag PT and Durston AJ (1993) The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 366: 340-344
37. Rigas JR, Francis PA, Muindi JRF, Kris MG, Huselton C, Degrazia F, Orazem JP, Young CW and Warrell RP (1993) Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. J Natl Cancer Inst 85: 1921-1926
38. Sacks PG, Harris D and Chou TC (1995) Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: A rationale for combination therapy with chemotherapeutic agents, Int J Cancer 61: 409-415
39. Sanquer S, Eller MS and Gilchrest BA (1993) Retinoids and state of differentiation modulate CRABP-II gene expression in a skin equivalent. J Invest Dermatol 100: 148-153
40. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press: New York
41. Stich HF, Hornby AD and Mathew B (1988) Response of oral leukoplakias to the administration of Vitamin A. Cancer Lett 40: 93-101
42. Takatsuka J, Takahashi N and De Luea L (1996) Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res 56: 675-678
43. Teerlink T, Copper MP, Klassen I and Braakhuis BJM (1997) Simultaneous analysis of retinol. retinoic acid isomers and polar metabolites using on-column concentration after single-phase fluid extraction. J Cromatoger B (in press)
44. Van Der Waal I (1992) Oral precancerous lesions - present knowledge. Deut Zahnartzl Z 47: 860-864
45. Wouters W, Van Dun J, Dillen A, Coene MC, Cools W and De Coster R (1992) Effects of lianrozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cells. Cancer Res 52: 2841-2846
46. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK and Lotan R (1994) Differential expression of nuclear retinoid receptors in normal, premalignant. and malignant head and neck tissues. Cancer Res 54: 3580-3587
47. Zou CP, Clifford JL, Xu XC, Sacks PG, Chambon P, Hong WK and Lotan R (1994) Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res 54: 5479-5487